Menu

UCSD Scores Legal Win over USC

A judge issued custody of an Alzheimer’s research project to the University of California, San Diego, after the lead researcher on the grant left the school and transferred to the University of Southern California.

Jul 27, 2015
Bob Grant

WIKIMEDIA, AMMODRAMUSTwo embattled California universities are no closer to reaching an amicable end to their disagreement after a superior court judge dealt a win to the University of California, San Diego (UCSD), which filed suit against the University of Southern California (USC) over a sizeable Alzheimer’s research grant from the National Institutes of Health (NIH). Alzheimer’s disease researcher Paul Aisen moved from UCSD to USC last month, taking with him a $55 million federal grant as well as many of his lab members. As a result, UCSD sued USC, alleging that Aisen illegally conspired to steal data and other assets associated with the grant. On Friday (July 24), San Diego Superior Court Judge Judith Hayes said she was issuing a preliminary injunction this week that would require UCS to cede control of the Alzheimer’s project.

“We all lose here,” Aisen wrote in an e-mail to The Los Angeles Times. “Science and public health lose when research is torn from the investigators with the passion, knowledge and skill to assure its success.”

The fact that the dispute between the California schools actually reached the courts made news because such jockeying between academic institutions—for star faculty, big grants, and new facilities—is commonplace. “We never wanted to resort to legal action, but when all reasonable requests to return what is the rightful property of UC San Diego were ignored, there was no alternative,” David Brenner, vice chancellor for health sciences at UCSD, said in a statement. “We are pleased with today's decision and believe it indicates the strength of our overall case.”

According to Hayes, USC is not to change existing data related to the project, and both universities now have to work out how to return full control of the database to UCSD. While UCSD has won the first battle in its legal dispute with USC, the court did not rule on the monetary damages the school is seeking. Hayes instead referred both institutions to a settlement judge, who might help the two institutions negotiate an agreement and avoid a jury trial.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.